Coaching for Performance Improvement in Opioid Use Disorder

Recruiting in Palo Alto (17 mi)

+3 other locations

Overseen byCharles Neighbors, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: NYU Langone Health

No Placebo Group

Trial Summary

What is the purpose of this trial?This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have developed specific training and coaching protocols as well as electronic clinical support tools to guide quality improvement that can be disseminated within New York and the rest of the country. The study will test a clinic-level intervention that uses external facilitators to provide guidance to addictions clinics and contain three key components: 1) training on data driven management; 2) training and guidance on patient-centered care and OUD medication; and 3) electronic tools for shared decision making and patient progress monitoring.

Eligibility Criteria

This trial is for substance use disorder clinics near New York City and the Capital Region with at least 50 clients yearly. It includes staff and patients on Medicaid, not co-insured with Medicare, from these clinics. Clinics with fewer than 50 annual clients are excluded.

Inclusion Criteria

I am enrolled in Medicaid and do not have Medicare coverage.

Substance use disorder clinics in the regions surrounding New York City and the New York Capital Region with annual census of 50 or greater

All staff and patients from participating clinics will be eligible to participate in the study

Exclusion Criteria

Patients who are not working/being treated at substance use disorder clinics with less than 50 clients per year

Participant Groups

The study tests a clinic-level intervention called Metrics-driven quality improvement (MDQI). It involves training in data management, patient-centered care for opioid disorders, and electronic tools for decision making and monitoring patient progress.

2Treatment groups

Experimental Treatment

Active Control

Group I: Metrics-driven quality improvement (MDQI) interventionExperimental Treatment1 Intervention

Group II: ControlActive Control1 Intervention